Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas
- 15 July 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (14), 4475-4483
- https://doi.org/10.1158/1078-0432.ccr-07-5199
Abstract
Purpose: In superficial basal cell carcinomas treated with photodynamic therapy with topical δ-aminolevulinic acid, we examined effects of light irradiance on photodynamic efficiency and pain. The rate of singlet-oxygen production depends on the product of irradiance and photosensitizer and oxygen concentrations. High irradiance and/or photosensitizer levels cause inefficient treatment from oxygen depletion in preclinical models. Experimental Design: Self-sensitized photobleaching of protoporphyrin IX (PpIX) fluorescence was used as a surrogate metric for photodynamic dose. We developed instrumentation measuring fluorescence and reflectance from lesions and margins during treatment at 633 nm with various irradiances. When PpIX was 90% bleached, irradiance was increased to 150 mW/cm2 until 200 J/cm2 were delivered. Pain was monitored. Results: In 33 superficial basal cell carcinomas in 26 patients, photobleaching efficiency decreased with increasing irradiance above 20 mW/cm2, consistent with oxygen depletion. Fluences bleaching PpIX fluorescence 80% (D80) were 5.7 ± 1.6, 4.5 ± 0.3, 7.5 ± 0.8, 7.4 ± 0.3, 12.4 ± 0.3, and 28.7 ± 7.1 J/cm2, respectively, at 10, 20, 40, 50, 60 and 150 mW/cm2. At 20-150 mW/cm2, D80 doses required 2.5-3.5 min; times for the total 200 J/cm2 were 22.2-25.3 min. No significant pain occurred up to 50 mW/cm2; pain was not significant when irradiance then increased. Clinical responses were comparable to continuous 150 mW/cm2 treatment. Conclusions: Photodynamic therapy with topical δ-aminolevulinic acid using ∼40 mW/cm2 at 633 nm is photodynamically efficient with minimum pain. Once PpIX is largely photobleached, higher irradiances allow efficient, rapid delivery of additional light. Optimal fluence at a single low irradiance is yet to be determined.Keywords
This publication has 41 references indexed in Scilit:
- Phototoxic reaction and porphyrin fluorescence in skin after topical application of methyl aminolaevulinateBritish Journal of Dermatology, 2007
- Fractionated Illumination Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolevulinic Acid Photodynamic TherapyJournal of Investigative Dermatology, 2006
- Important Factors for Pain during Photodynamic Therapy for Actinic KeratosisPublished by Medical Journals Sweden AB ,2006
- A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (AmetopR) for pain relief during topical photodynamic therapyBritish Journal of Dermatology, 2004
- Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatmentBritish Journal of Dermatology, 2003
- Laser and Non-laser Light Sources for Photodynamic TherapyLasers in Medical Science, 2002
- Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trialBritish Journal of Dermatology, 2001
- Blood Perfusion Studies on Basal Cell Carcinomas in Conjunction with Photodynamic Therapy and Cryotherapy Employing Laser-Doppler Perfusion ImagingActa Dermato-Venereologica, 2000
- Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imagingBritish Journal of Dermatology, 1997
- Analytical model for extracting intrinsic fluorescence in turbid mediaApplied Optics, 1993